MMedication Read More Mounjaro’s Label Expands; Type 1 Diabetes on the Rise; Testosterone and AfibSeptember 2, 2026 The FDA expanded the indication for tirzepatide (Mounjaro) to include reducing the risk of major adverse cardiovascular events…